Colorectal cancer is a leading cause of morbidity and mortality worldwide. As such, there are recognized guidelines in the screening of this preventable cancer. There are differences in opinion regarding screening recommendations between the European and United States Cancer Prevention Societies. Screening colonoscopy is an option for routine screening for colorectal cancer in asymptomatic adults. It is a day procedure that is conducted both in hospital and specialized outpatient endoscopy suites. Serious harm is in the region of 3 per 1,000 examinations [Am J Gastroenterol. 2016 Aug;111(8):1092-101]. Splenic injury is a rare complication of colonoscopy whose frequency is unclear. Conservative management of splenic injury is desirable in order to preserve immunocompetence. We present a case in which a previously healthy 59-year-old female developed a splenic injury and later pleural effusion after screening colonoscopy.
Introduction
Colorectal cancer (CRC) is a common illness that has worldwide implications. It is currently the third most commonly diagnosed cancer in men and the second most commonly diagnosed cancer in females globally [1] . This accounts for around 1.5 million new cases resulting in approximately 800,000 deaths per year [2] . There is a global variance in the incidence of CRC with the highest rates reported in North America, Europe, Australia, and New Zealand. It is postulated that this difference can be accounted by both genetic and environmental factors such as diet and exercise. Additional risk factors for CRC include low socioeconomic status, physical inactivity, smoking, and obesity [3] [4] [5] .
The aim of CRC screening is to identify premalignant states and possibly prevent future cases of invasive CRC. Currently available measures include stool studies such as guaiac fecal occult blood (gFOBT), fecal immunohistochemistry tests (FIT), fecal DNA tests, and combinations of both FIT and DNA (FIT-DNA). Imaging studies include CT colonography. Direct visualization is only possible with invasive sigmoidoscopy or colonoscopy. Direct visualization with an endoscope has the advantage of being possibly preventive of eventual CRC. This is accomplished by resecting premalignant and high-grade adenomas. There are varying guidelines regarding CRC in different parts of the world for patients of average risk for CRC.
The options supported by the United States Preventative Task Force (USPTF) include colonoscopy, FIT, CT colonography, and gFOBT. They recommend individualizing testing based on preference, comorbidities, and local expertise. However, colonoscopy remains a recommended option for asymptomatic individuals of average risk [6] . By contrast, while colonoscopy is an option, the current European Colorectal Screening Guidelines Work Group [7] from 2013 recommend stool studies such as FIT and gFOBT as first line. They went on to acknowledge the relative lack of evidence as colonoscopy alone as an effective CRC screening intervention.
Screening colonoscopy is a day procedure that is conducted both in hospital and in specialized outpatient endoscopy suites. Serious harm is in the region of 3 per 1,000 examinations [8] . More commonly reported complications include bowel perforation, postpolypectomy hemorrhage, and risks related to sedation. Splenic injury is a rare complication of colonoscopy whose frequency is unclear.
Splenic injury with hemorrhage is a potentially life-threatening condition whose treatment has traditionally been emergent splenectomy. Spleen preserving nonoperative and salvage techniques are attractive to avoid postsplenectomy sepsis, surgical complications/risk, and early infections in the postoperative period [9, 10] . Splenic injury after colonoscopy was first reported in 1974 [11] and is rare but likely underreported. Splenic injury/hematoma have been associated with pleural effusion [12] ; however, the frequency is not clearly defined. Recurrence is possible but resolves after elective splenectomy [12] .
We present a case in which a previously healthy 59-year-old female of average risk for CRC developed a splenic injury and later pleural effusion after screening colonoscopy.
Case Report
A 59-year-old female underwent screening colonoscopy one morning after an uneventful bowel preparation. Her past medical history included osteoarthritis, gastrointestinal reflux disease, obesity, and cholelithiasis. Her past surgical history was significant for remote cholecystectomy, two caesarian sections, and hysterectomy. Medications included estrogen, omeprazole, and ibuprofen. She tolerated the procedure well and was told by verbal report that there were no adenomas detected. She was discharged from the endoscopy suite feeling well.
Approximately 3 h after the colonoscopy, she developed gradual onset but progressively worsening left upper quadrant pain. The pain was described as sharp and radiated to her left On arrival to the emergency room (ER), her vital signs were significant for hypotension (HR 75, RR 16 100% RA, BP 73/38, T 36.4); however, this resolved after 2 L of intravenous fluid bolus (111/87). Initial investigations were significant for a Hb of 10.1 g/dL and contrast CT of abdomen and pelvis was significant for a 4-cm perisplenic hematoma ( Fig. 1) with midline shift and acute blood surrounding the spleen. There was no extravasation of arterial blood noted. The decision was made to pursue conservative management with pain control and serial Hb measurements every 4 h. Over the first 2 days, her Hb gradually trended down but did not fall below 8 mg/dL. On day 3 of admission/after colonoscopy, she required a single unit of PRBC as her Hb fell to 7.3 g/dL. Posttransfusion Hb remained stable at 9.0 g/dL; however, she remained in the hospital for a further 4 days for observation, serial Hb measurements, and pain control. She was discharged home feeling well on day 7.
She presented back to Blake Medical Center 1 month after her discharge. Since leaving the hospital, she had developed gradually worsening exertional shortness of breath and left sided chest pain. The chest pain started approximately 2 weeks after her discharge. It was described as a gradual onset but constant, sharp, pleuritic, nonradiating, and graded as 4/10 in severity. There were no other aggravating or relieving factors. The shortness of breath was also insidious in onset with gradual initial symptoms only present on moderate exertion. She became concerned and decided to present to the ER when she became short of breath on minimal exertion (walking 3 m).
On arrival to the ER, her vitals were within normal limits; however, she required 2 L of oxygen by nasal cannula to maintain oxygen saturations above 95%. Initial investigations were significant for complete opacification of the left hemithorax (Fig. 2) . CT of the thorax revealed massive low attenuating pleural effusion causing compressive atelectasis. Repeat CT of the abdomen and pelvis showed that the perisplenic hematoma had increased to 8 × 8 × 6 cm but was otherwise unremarkable and unchanged. Chest tube insertion was undertaken. The fluid satisfied lights criteria and was thought to be an exudate; however, culture, AFB, and cytology were all negative. The chest tube was removed after 3 days and drained a total of 1.35 L of serous straw-colored fluid. There was no reaccumulation and she was discharge home 24 h later. For the previous 12 months, there have been no further events.
Discussion
Screening colonoscopy is a safe outpatient procedure that rarely results in significant morbidity or mortality. The USPSTF recommendations for colon cancer screening include colonoscopy starting at age 50 years and continuing until 75 years. Asymptomatic individuals older than 75 years should be evaluated on a case-by-case basis. The European guidelines differ in that, while colonoscopy alone is an option, the recommendation is to start with stool studies. Complications directly related to colonoscopy include bleeding after polypectomy, perforation, and infection. These are more common in patients of advanced age and comorbidities [13] .
Splenic injury after colonoscopy is a rare but likely underreported complication of colonoscopy. Reviewing PubMed and MEDLINE yielded 174 cases between 1974 and 2018 globally. Risk factors for iatrogenic splenic injury include splenomegaly, previous abdominal surgeries, malignancy, diverticulitis, and peripheral artery disease [14, 15] . Potential mechanisms include excess traction on the splenocolic ligament [16, 17] , rupture of splenocolic adhesions [18] , and direct trauma to the spleen [17] .
Pleural effusion post blunt injury to the spleen is a known complication whose incidence is not clearly defined. With the increasing prevalence of spleen sparing interventions [19] [20] [21] [22] for splenic injury symptomatic pleural effusion may become more common and should be considered. Being that re-accumulation has been described in the literature, these patients need close follow-up after standard management and investigation for pleural effusion.
Differentiating potentially serious complications of colonoscopy from expected abdominal pain related to insufflation of air can be difficult. Patients with Kehr's sign, which consists of LUQ, left chest, or left shoulder pain that is pleuritic, should be investigated for splenic injury. Splenic injury should be considered in the differential diagnosis in high-risk patients with post colonoscopy abdominal pain as this condition may require emergent intervention.
This case brings to light that while colonoscopy is a well-tolerated procedure, it remains an invasive option that can occasionally be associated with significant morbidity. The advantage of stool testing is that they are noninvasive and a negative result could preclude colonoscopy. Disadvantages of this approach include being unable to directly address premalignant adenomas. With the growing availability and decreasing cost of combined FIT-DNA testing, they have the potential to be the preferred initial testing modality in previously asymptomatic patients of average CRC risk.
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